A critical advance in cancer research is occurring with the use of mini-antibodies to re-engage mutated p53. This crucial tumor suppressor protein is frequently lost in various types of malignancies, resulting https://bookmarkssocial.com/story21868205/nanobodies-restore-the-p53-protein-the-new-pathway-for-tumor-treatment